Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis". — Andrea Messori (2019) | RDL Network
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis".
Flora Peyvandi, Syna Miri, Paolo Bucciarelli, Carla Valsecchi, Lucia Schiavone, Marco Boscarino, Roberta Palla, Pier Mannuccio Mannucci, Frits R. Rosendaal
Seied Mehdi Miri, Frits R. Rosendaal, Kaan Kavaklı, Peyman Eshghi, Soha Mohammadi Moghaddam, Mohsen Saleh Elalfy, Susan Halimeh, Dilek Gürlek Gökçebay, Namık Yaşar Özbek, Tıraje Celkan, Ali Akbar Mohammadi, Mehran Karimi, Barış Yılmaz, Canan Albayrak, Burçak Tatlı Güneş, Zühre Kaya, Yılmaz Ay, Sinan Akbayram, Hale Ören, Flora Peyvandi
Research and Practice in Thrombosis and Haemostasis
Created:June 19, 2026
Sinan Akbayram
Nazan Sarper,
Pier Mannuccio Mannucci,
Flora Peyvandi
Research and Practice in Thrombosis and Haemostasis
Discussion(0)
No comments yet. Be the first to comment.